Case File
efta-02021174DOJ Data Set 10OtherEFTA02021174
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-02021174
Pages
5
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
jeevacation
mail.com 'eevacation
mail.com]; jeffrey epsteinlieevacation©gmail.comj
Cc:
Ens, Amand
From:
Barrett, Paul S
Sent:
Mon 10/3/2011 1:53:17 PM
Subject: RE: Update
Jeffrey
We are now up $1.1MM for the year and down $5.8MM since inception.
We are still seeing more funding stress in European banks. We own 2.5MM face of the ING Pfds which I
think we should sell. The company tried to call these at par earlier in the year but the Dutch govt
rejected this request and the long spread duration embedded here makes us think we should cut. We
paid 97 for them. Would work 72 to sell.
In the US we should sell the 2MM of our Wachovia Pfds we own. Same story — just looking to reduce
financial pfd exposure. Paid 93.50. Would work 83.00 to sell.
We have protection on half our MS and Telefonica positions.
Corn was down 5% on Friday's inventory report. We are still up $1.SMM on this position. I think we
spend some of these profits on a 1 month put. If China fears accelerate there could be significant
downside from here and would like to protect these gains.
Let me know
Paul
EFTA_R1_00526818
EFTA02021174
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10019
From: jeffrey epstein [mailto:jeevacation©gmail.com]
Sent: Tuesday, September 27, 2011 2:26 PM
To: Barrett, Paul S
Subject: Re: Update
Ok
Sorry for all the typos .Sent from my iPhone
On Sep 27, 2011, at 8:23 PM, "Barrett, Paul S"
rote:
Jeffrey
I think we should take advantage of the recent rally to trim some positions that either
have limited upside (like our Barclays Pfds and Citi Pfds) or are at risk for further
downside if Europe does not ratify the expanded EFSF.
EFTA_R1_00526818
EFTA02021175
Recommendation:
- trim our CIT from 10MM to 5MM. Would sell $2.5MM of both the 2016 and the
2017 maturity. We are up on both positions
- collar 'A our MS exposure for 1 month. This would entail buying a 14 put and
selling a 17 call. Cost around 10c/share
- collar'/ out Telefonica position for 1 month. 13.50/15 collar. Cashless.
I will call you to discuss.
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10019
From: Barrett, Paul S
Sent: Wednesday, September 21, 2011 3:52 PM
To: 'Jeffrey Epstein'
Subject: Update
Hi Jeffrey
EFTA_R1_00526820
EFTA02021176
We are still doing some more credit work before we close the $5MM Harrah's note.
Since the end of August the account is down around $2.7MM (was flat at the end of Aug).This
translates into -$6.98MM for 2010 and +$4.25MM YTD for 2011.
This has been due to (changes since End of August):
SGD down 5% ($500K)
INR down 5% ($500K
We switched both of these forwards into options so we have limited downside
from here on out
CADJPY down 150K [We are long the 83.25 CAD Call and Short the 76.00 Put with a
knock in at 71; spot at 76.50; knock in 7% away)
Oil call down 140K
Corn down 600K
ING Pfds down 200K
MS Note knocked in down 140K
Telefonica note down 300K [Stock is trading below 2009 lows; only 35% of their revenue
comes from Spain; would HOLD]
I would like to reduce further downside.
I think the cheapest protection out there remains buying CDS on Asia. For example
Indonesia CDS costs 220bps. It got as wide as 1200bps in 2008. It feels like Asian credit
spreads remain one of the few things that have not moved and could provide some
cheaper tail risk if things deteriorate further.
Financial Pfds remain our largest notional exposure (around $20MM). I think we should
reduce some exposure here. Would involve selling some of JPM, Barclays and Citigroup.
BAC and WFC was downgraded today and would also trim those positions.
EFTA_R1_00526821
EFTA02021177
Do you have time to discuss?
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10019
This email is confidential and subject to important disclaimers and conditions
including on offers for the purchase or sale of securities, accuracy and
completeness of information, viruses, confidentiality, legal privilege, and legal
entity disclaimers, available at httpl/www.ipmorgan.com/pagesidisclosures/email.
EFTA_R1_00526822
EFTA02021178
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
gmail.comDomain
mail.comDomain
www.ipmorgan.comRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.